Skip to main content
Top
Published in: Abdominal Radiology 11/2016

Open Access 01-11-2016

Comparison of clinical MRI liver iron content measurements using signal intensity ratios, R 2 and R 2*

Authors: Jurgen H. Runge, Erik M. Akkerman, Marian A. Troelstra, Aart J. Nederveen, Ulrich Beuers, Jaap Stoker

Published in: Abdominal Radiology | Issue 11/2016

Login to get access

Abstract

Purpose

To compare three types of MRI liver iron content (LIC) measurement performed in daily clinical routine in a single center over a 6-year period.

Methods

Patients undergoing LIC MRI-scans (1.5T) at our center between January 1, 2008 and December 31, 2013 were retrospectively included. LIC was measured routinely with signal intensity ratio (SIR) and MR-relaxometry (R 2 and R 2*) methods. Three observers placed regions-of-interest. The success rate was the number of correctly acquired scans over the total number of scans. Interobserver agreement was assessed with intraclass correlation coefficients (ICC) and Bland–Altman analysis, correlations between LICSIR, R 2, R 2*, and serum values with Spearman’s rank correlation coefficient. Diagnostic accuracies of LICSIR, R 2 and serum transferrin, transferrin-saturation, and ferritin compared to increased R 2* (≥44 Hz) as indicator of iron overload were assessed using ROC-analysis.

Results

LIC MRI-scans were performed in 114 subjects. SIR, R 2, and R 2* data were successfully acquired in 102/114 (89%), 71/114 (62%), and 112/114 (98%) measurements, with the lowest success rate for R 2. The ICCs of SIR, R 2, and R 2* did not differ at 0.998, 0.997, and 0.999. R 2 and serum ferritin had the highest diagnostic accuracies to detect elevated R 2* as mark of iron overload.

Conclusions

SIR and R 2* are preferable over R 2 in terms of success rates. R 2*’s shorter acquisition time and wide range of measurable LIC values favor R 2* over SIR for MRI-based LIC measurement.
Appendix
Available only for authorised users
Literature
11.
go back to reference Krafft AJ, Loeffler RB, Song R, et al. (2015) Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T. Magn Reson Med. doi:10.1002/mrm.25868 PubMed Krafft AJ, Loeffler RB, Song R, et al. (2015) Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T. Magn Reson Med. doi:10.​1002/​mrm.​25868 PubMed
12.
go back to reference Yokoo T, Yuan Q, Senegas J, Wiethoff AJ, Pedrosa I (2015) Quantitative R2* MRI of the liver with rician noise models for evaluation of hepatic iron overload: Simulation, phantom, and early clinical experience. J Magn Reson Imaging 42:1544–1559. doi:10.1002/jmri.24948 CrossRefPubMed Yokoo T, Yuan Q, Senegas J, Wiethoff AJ, Pedrosa I (2015) Quantitative R2* MRI of the liver with rician noise models for evaluation of hepatic iron overload: Simulation, phantom, and early clinical experience. J Magn Reson Imaging 42:1544–1559. doi:10.​1002/​jmri.​24948 CrossRefPubMed
15.
go back to reference Swinkels DW, van Bokhoven MA, Castel A, et al. (2007) Richtlijn Diagnostiek en behandeling van hereditaire hemochromatose. Utrecht: Nederlandse Internisten Vereeniging en Nederlandse Vereniging voor Klinische Chemie Swinkels DW, van Bokhoven MA, Castel A, et al. (2007) Richtlijn Diagnostiek en behandeling van hereditaire hemochromatose. Utrecht: Nederlandse Internisten Vereeniging en Nederlandse Vereniging voor Klinische Chemie
16.
go back to reference Meloni A, Luciani A, Positano V, et al. (2011) Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging 33(2):348–355. doi:10.1002/jmri.22417 CrossRefPubMed Meloni A, Luciani A, Positano V, et al. (2011) Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging 33(2):348–355. doi:10.​1002/​jmri.​22417 CrossRefPubMed
23.
go back to reference Akkerman EM, Runge JH, Troelstra MA, Nederveen AJ, Stoker J (2015) Non-linear relationship between estimated liver iron concentration and R2*. ISMRM 3268 Akkerman EM, Runge JH, Troelstra MA, Nederveen AJ, Stoker J (2015) Non-linear relationship between estimated liver iron concentration and R2*. ISMRM 3268
24.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
25.
26.
29.
go back to reference Butensky E, Fischer R, Hudes M, et al. (2005) Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 123:146–152. doi:10.1309/PUUXEGXDLH26NXA2 CrossRefPubMed Butensky E, Fischer R, Hudes M, et al. (2005) Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 123:146–152. doi:10.​1309/​PUUXEGXDLH26NXA2​ CrossRefPubMed
Metadata
Title
Comparison of clinical MRI liver iron content measurements using signal intensity ratios, R 2 and R 2*
Authors
Jurgen H. Runge
Erik M. Akkerman
Marian A. Troelstra
Aart J. Nederveen
Ulrich Beuers
Jaap Stoker
Publication date
01-11-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0831-7

Other articles of this Issue 11/2016

Abdominal Radiology 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.